Strive Asset Management LLC Lowers Holdings in iShares U.S. Pharmaceuticals ETF $IHE

Strive Asset Management LLC decreased its position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 27.9% in the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,846 shares of the company’s stock after selling 1,103 shares during the period. Strive Asset Management LLC’s holdings in iShares U.S. Pharmaceuticals ETF were worth $201,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the company. LPL Financial LLC boosted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 47.6% in the first quarter. LPL Financial LLC now owns 119,866 shares of the company’s stock valued at $8,458,000 after purchasing an additional 38,678 shares during the period. Goldman Sachs Group Inc. lifted its holdings in iShares U.S. Pharmaceuticals ETF by 4.8% during the first quarter. Goldman Sachs Group Inc. now owns 104,815 shares of the company’s stock worth $7,396,000 after buying an additional 4,815 shares during the period. Royal Bank of Canada lifted its holdings in iShares U.S. Pharmaceuticals ETF by 0.3% during the first quarter. Royal Bank of Canada now owns 101,984 shares of the company’s stock worth $7,197,000 after buying an additional 325 shares during the period. Two Sigma Investments LP purchased a new stake in iShares U.S. Pharmaceuticals ETF during the fourth quarter worth $4,430,000. Finally, Citadel Advisors LLC lifted its holdings in iShares U.S. Pharmaceuticals ETF by 265.7% during the fourth quarter. Citadel Advisors LLC now owns 18,708 shares of the company’s stock worth $1,229,000 after buying an additional 13,592 shares during the period.

iShares U.S. Pharmaceuticals ETF Stock Up 0.1%

iShares U.S. Pharmaceuticals ETF stock opened at $71.54 on Wednesday. The business has a fifty day moving average of $68.57 and a two-hundred day moving average of $67.29. The firm has a market cap of $586.63 million, a P/E ratio of 17.75 and a beta of 0.70. iShares U.S. Pharmaceuticals ETF has a twelve month low of $58.97 and a twelve month high of $73.28.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.